Press Releases and Events
PRESS RELEASES
Press Release | March 1, 2022
Press Release | February 28, 2022
Crinetics Pharmaceuticals and Sanwa Kagaku Kenkyusho Enter into Exclusive Licensing Agreement for the Development and Commercialization of Paltusotine in Japan
READ MORE
Press Release | February 9, 2022
Crinetics Pharmaceuticals to Participate in SVB Leerink Global Healthcare Conference
READ MORE
Press Release | February 1, 2022
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
READ MORE
Press Release | January 12, 2022
Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 40th Annual J.P. Morgan Healthcare Conference
READ MORE
Press Release | January 5, 2022
Crinetics Pharmaceuticals Adds Board Member with Global Rare Disease Expertise with Appointment of Rogério Vivaldi Coelho, M.D., M.B.A.
READ MORE
Press Release | November 18, 2021
Crinetics Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference
READ MORE
Press Release | November 8, 2021
Crinetics Pharmaceuticals Presenting New Data from Open Label Extension Trial of Paltusotine in Acromegaly at the Society for Endocrinology BES Congress
READ MORE
Press Release | November 5, 2021
Crinetics Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
READ MORE
Press Release | October 25, 2021
Crinetics Pharmaceuticals Announces Closing of Public Offering of Common Stock
READ MORE
SIGN UP
WEBCAST
PRESENTATIONTransforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine-rooted care.
Email Signup
You are now leaving Crinetics.com
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
